Skip to Main Content

Author Details

Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
1996
112
36
PMIDPaper TitleJournal TitlePublished Year
38011024Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.Am J Clin Oncol2024
36635119Addressing the genetic/nongenetic duality in cancer with systems biology.Trends Cancer2023
37644992Broadening the scope of artificial intelligence in oncology.Lancet Reg Health Am2023
37186595American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma.JAMA Oncol2023
37079324Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial.JAMA Oncol2023
37342208Evaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform.Phys Imaging Radiat Oncol2023
37099735Race, Ethnicity, and Socioeconomic Factors as Determinants of Cachexia Incidence and Outcomes in a Retrospective Cohort of Patients With Gastrointestinal Tract Cancer.JCO Oncol Pract2023
37095748Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief Report.JTO Clin Res Rep2023
37294262Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.Pract Radiat Oncol2023
37092555Tumor loss-of-function mutations in STK11/LKB1 induce cachexia.JCI Insight2023
34555519Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis.Clin Gastroenterol Hepatol2022
35649502Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective.J Thorac Oncol2022
35785158Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia.Front Oncol2022
35814438Primary Tumor Fluorine-18 Fluorodeoxydglucose (<sup>18</sup>F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival.Front Oncol2022
35747801Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and Survival.Front Oncol2022
36148376T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer.Adv Radiat Oncol2022
36139689The Evolving Interplay of SBRT and the Immune System, along with Future Directions in the Field.Cancers (Basel)2022
36165100A preponderance of gastrointestinal cancer patients transition into cachexia syndrome.J Cachexia Sarcopenia Muscle2022
36395804Local Therapy for Oligometastatic Disease-Cart Before the Horse?Int J Radiat Oncol Biol Phys2022
35124269Reply.Clin Gastroenterol Hepatol2022
35307115The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease.Semin Radiat Oncol2022
35024789Hypofractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer-Does Size Matter?-Reply.JAMA Oncol2022
34090650Local Ablative Therapy in Oligometastatic NSCLC.Semin Radiat Oncol2021
35721304The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancer.JCSM Clin Rep2021
33691460Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.Ann Palliat Med2021
33748712LIFR-α-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease.iScience2021
34944813Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.Cancers (Basel)2021
34902832Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021
34383006Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.JAMA Oncol2021
34430379Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative review.Transl Lung Cancer Res2021
34430372Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.Transl Lung Cancer Res2021
34127511Radiation Therapy in Non-Small-Cell Lung Cancer.Cold Spring Harb Perspect Med2021
34268489Deep Learning-Based COVID-19 Pneumonia Classification Using Chest CT Images: Model Generalizability.Front Artif Intell2021
32342863Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.Radiother Oncol2020
31841363Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.J Clin Oncol2020
33103159JAK Inhibitors Suppress Cancer Cachexia-Associated Anorexia and Adipose Wasting in Mice.JCSM Rapid Commun2020
32589990Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.Int J Radiat Oncol Biol Phys2020
32388150Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document.Radiother Oncol2020
32347302Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.Neuro Oncol2020
32398326Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617.Clin Cancer Res2020
30562615Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials.Pract Radiat Oncol2019
31673523Changing equipoise in the landscape of radiation for oligometastatic lung cancer.Transl Lung Cancer Res2019
30943123Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.J Clin Oncol2019
31109801Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.Clin Genitourin Cancer2019
30684664A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.Int J Radiat Oncol Biol Phys2019
30513377Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys2019
28973074Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.JAMA Oncol2018
29891202Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR.Int J Radiat Oncol Biol Phys2018
30046014Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin.JCI Insight2018
30206497The current state of oligometastatic and oligoprogressive non-small cell lung cancer.J Thorac Dis2018
  • 1 - 50 of 112

Recommended Authors

Stanford University
Career Start Year 2014
Number of shared co-authors 2
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 4
Emory University
Career Start Year 2011
Number of shared co-authors 0
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 3
University of Toronto
Career Start Year 2010
Number of shared co-authors 2
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 5
University of California los angeles
Career Start Year 2007
Number of shared co-authors 2
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 5
The University of Manchester
Career Start Year 2000
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 5
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 7
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 2
University of British Columbia
Career Start Year 1995
Number of shared co-authors 1
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Maastricht University
Career Start Year 1992
Number of shared co-authors 2
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 8
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 7
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 1

Collaborators

University of Texas Southwestern Medical Center
Co-authored papers 12
University of Texas Southwestern Medical Center
Co-authored papers 11
University of Western Ontario
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Johns Hopkins University School of Medicine
Co-authored papers 6
Maastro Clinic
Co-authored papers 4
University of Texas Southwestern Medical Center
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Western University and London Regional Cancer Program
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Houston Methodist Research Institute
Co-authored papers 1
Texas Center for Proton Therapy
Co-authored papers 1
Siteman Cancer Center, Washington University School of Medicine
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Co-authored papers 1
UT Southwestern Medical Center
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Co-authored papers 1